The drugs PAB make seem to work.
Just cant make the drugs yet after many, many years and many, many shareholder dollars.
I'm sure if they have a manufacture breakthrough, so will the share price.
My gut feeling is they cant mass produce IgM antibodies at scale consistently.
This is the reason to move into CAR-T cells and a sp. below 2 cents.
Ann: Patrys 2014 AGM Presentation, page-26
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $6.723K | 1.120M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 9665158 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 597624 | 2 |
View Market Depth
| Last trade - 14.44pm 23/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |